Srinath Sundararajan
Overview
Explore the profile of Srinath Sundararajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pulluri B, Kumar A, Shaheen M, Jeter J, Sundararajan S
Pharmacol Res
. 2017 Jul;
123:95-102.
PMID: 28690075
Immunotherapy with checkpoint inhibitors targeting CTLA-4 and/or PD-1 receptors independent of the BRAF mutational status and targeted therapy with BRAF and MEK inhibitors in BRAF V600 mutated patients have taken...
12.
Skrepnik T, Sundararajan S, Cui H, Stea B
Oncoimmunology
. 2017 Apr;
6(3):e1283461.
PMID: 28405509
: To identify the optimal sequencing and timing of immunotherapy (IT) and stereotactic radiosurgery (SRS) for melanoma brain metastases (MBMs). : The elapsed days between IT and SRS were correlated...
13.
Kumar A, Sundararajan S, Puvvada S, Persky D
Curr Treat Options Oncol
. 2016 Jul;
17(9):45.
PMID: 27423794
The seminal SWOG trial S8736 trial established the success of a short course of chemotherapy followed by involved field radiation in treating limited stage aggressive NHL lymphoma. Addition of rituximab...
14.
Nakhla S, Sundararajan S
Case Rep Oncol Med
. 2016 May;
2016:8961486.
PMID: 27144043
Mediastinal germ cell tumors are extragonadal germ cell tumors (EGGCTs) commonly seen in children and young adults. They are more common in men. Clinically they are classified as teratomas, seminomas,...
15.
Sundararajan S, Kumar A, Poongkunran M, Kannan A, Vogelzang N
Future Oncol
. 2016 Feb;
12(8):1067-80.
PMID: 26901457
Anticancer treatment has evolved enormously over the last decade. Drugs targeting receptor tyrosine kinases, VEGFR and EGFR have changed the treatment landscape of certain cancers and have shifted the theme...
16.
Sundararajan S, Kumar A, Korde N, Agarwal A
Curr Hematol Malig Rep
. 2016 Feb;
11(2):102-10.
PMID: 26894382
Smoldering multiple myeloma (SMM) is a pre-malignant condition with an inherent risk for progression to multiple myeloma (MM). The 2014 IMWG guidelines define smoldering multiple myeloma as a monoclonal gammopathy...
17.
Sundararajan S, Chen H, Kumar A, Tus K, Yeager A, Puvvada S
Leuk Lymphoma
. 2015 Dec;
57(7):1735-8.
PMID: 26700138
No abstract available.
18.
Nakhla S, Murakami T, Sundararajan S
Case Rep Oncol Med
. 2015 Dec;
2015:242760.
PMID: 26682079
McKittrick-Wheelock Syndrome is a rare disorder, noted for electrolyte and fluid depletion caused by secretory colorectal adenomas and carcinomas. We report here the first reported case of a 55-year-old man...
19.
Sundararajan S, Vogelzang N
Future Oncol
. 2015 Aug;
11(16):2299-306.
PMID: 26260808
Oncologic therapeutics has evolved enormously as we entered the 21st century. Unfortunately, the treatment of advanced urothelial cancer has remained unchanged over the last two decades despite a better understanding...
20.
Sundararajan S, Braunhut B, Ahmann F, Agarwal A
Case Rep Oncol Med
. 2014 Jul;
2014:250531.
PMID: 25045560
Testicular germ cell tumors (GCTs) metastasize in a very predictable fashion involving the retroperitoneal nodes first followed by hematogenous spread to distant organs like lungs, liver, and brain. Metastasis to...